Skip to content

Rapport Therapeutics, Inc. RAPP Change in Other Assets

Change in Other Assets at other companies

Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$12.43M+269%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$1.48M+60.0%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
-$672K+89.9%
Biohaven logo
BiohavenBHVN
-$12.56M-274%
Septerna, Inc. logo
Septerna, Inc.SEPN
$294K-39.8%
PVL
Palvella TherapeuticsPVLA
$357K+144%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$24.2M+10.7%
Net income-$19.9M+17.5%
EPS (diluted)-$0.42+38.2%

Balance sheet

See full
Cash & equivalents$78.1M+35.5%
Total debt$10.8M+37.8%
Total equity$471.5M+65.0%
Total assets$497.6M+64.7%

Cash flow

See full
Operating cash flow-$13.1M+35.5%
CapEx$86.0K-70.4%
Free cash flow-$13.1M+36.0%

Valuation

See full
Market cap$1.86B+309%
Enterprise value$1.79B+352%

Returns & leverage

See full
Return on equity-28.3%
Debt / equity0.0×
Current ratio27.1×-3.9×

Where this comes from

Reported directly by Rapport Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s change in other assets?
Rapport Therapeutics, Inc. (RAPP) reported change in other assets of -$814K in Q1 2026.
How has Rapport Therapeutics, Inc.'s change in other assets changed year-over-year?
Rapport Therapeutics, Inc.'s change in other assets decreased by 198.7% year-over-year, from $825K to -$814K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.